Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation

Neurobiology of Aging

Volumn 33, Issue 8, 2012, Pages 1843.e9-1843.e17

  Proitsi, Petroula ^a   Lupton, Michelle K ^a   Dudbridge, Frank ^b   Tsolaki, Magda ^c   Hamilton, Gillian ^d   Daniilidou, Makrina ^c   Pritchard, Megan ^a   Lord, Kathryn ^a   Martin, Belinda M ^a   Craig, David ^e   Todd, Stephen ^e   McGuinness, Bernadette ^e   Hollingworth, Paul ^f   Harold, Denise ^f   Kloszewska, Iwona ^g   Soininen, Hilkka ^h   Mecocci, Patrizia ⁱ   Velas, Bruno ^j   Gill, Michael ^k   Lawlor, Brian ^l   Rubinsztein, David C ^m   Brayne, Carol ⁿ   Passmore, Peter A ^e   Williams, Julie ^f   Lovestone, Simon ^a   Powell, John F ^a   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g MEDICAL UNIVERSITY OF LODZ   (Poland)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

^j HÔpitaux de Toulouse ^*  (France)

^k TRINITY COLLEGE DUBLIN   (Ireland)

^l ST JAMES S HOSPITAL   (Ireland)

^m UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

Age related macular degeneration (AMD); Alzheimer's disease (AD); Complement pathway; Genetic models; Single nucleotide polymorphisms (SNPs)

Indexed keywords

ADULT; AGE RELATED MACULOPATHY SUSCEPTIBILITY PROTEIN 2 GENE; AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; COMPLEMENT COMPONENT 2 GENE; COMPLEMENT COMPONENT 3 GENE; COMPLEMENT FACTOR B GENE; COMPLEMENT FACTOR H GENE; COMPLEMENT GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; CLINICAL TRIAL; COMORBIDITY; COMPLEMENT CLASSICAL PATHWAY; EUROPE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; RETINA MACULA DEGENERATION; RISK ASSESSMENT;

COMPLEMENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COMORBIDITY; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; EUROPE; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT;

EID: 84862830163     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.12.036     Document Type: Article

References (46)

1. Anderson D.H., Mullins R.F., Hageman G.S., Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol 2002, 134:411-431.
2. Baird P.N., Richardson A.J., Robman L.D., Dimitrov P.N., Tikellis G., McCarty C.A., Guymer R.H. Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD). Hum. Mutat 2006, 27:337-342.
3. Baker M.L., Wang J.J., Rogers S., Klein R., Kuller L.H., Larsen E.K., Wong T.Y. Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. Arch. Ophthalmol 2009, 127:667-673.
4. Bergeron-Sawitzke J., Gold B., Olsh A., Schlotterbeck S., Lemon K., Visvanathan K., Allikmets R., Dean M. Multilocus analysis of age-related macular degeneration. Eur. J. Hum. Genet 2009, 17:1190-1199.
5. Bradt B.M., Kolb W.P., Cooper N.R. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J. Exp. Med 1998, 188:431-438.
6. Charbel Issa P., Chong N.V., Scholl H.P. The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application. Graefes Arch. Clin. Exp. Ophthalmol 2011, 249:163-174.
7. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
8. Eikelenboom P., Hack C.E., Rozemuller J.M., Stam F.C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol 1989, 56:259-262.
9. Eikelenboom P., Stam F.C. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol 1982, 57:239-242.
10. Fonseca M.I., Chu S.H., Berci A.M., Benoit M.E., Peters D.G., Kimura Y., Tenner A.J. Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease. J. Neuroinflammation 2011, 8:4.
11. Fonseca M.I., Zhou J., Botto M., Tenner A.J. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J. Neurosci 2004, 24:6457-6465.
12. Francis P.J., Hamon S.C., Ott J., Weleber R.G., Klein M.L. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J. Med. Genet 2009, 46:300-307.
13. Gatta L.B., Vitali M., Zanola A., Venturelli E., Fenoglio C., Galimberti D., Scarpini E., Finazzi D. Polymorphisms in the LOC387715/ARMS2 putative gene and the risk for Alzheimer's disease. Dement. Geriatr. Cogn. Disord 2008, 26:169-174.
14. Gauderman W.J. Sample size requirements for matched case-control studies of gene-environment interaction. Stat. Med 2002, 21:35-50.
15. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., Smith R.T., Hageman G.S., Dean M., Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet 2006, 38:458-462.
16. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res 2001, 20:705-732.
17. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
18. Hamilton G., Proitsi P., Williams J., O'Donovan M., Owen M., Powell J., Lovestone S. Complement factor H Y402H polymorphism is not associated with late-onset Alzheimer's disease. Neuromol. Med 2007, 9:331-334.
19. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van B.C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease [erratum in 2009 41, 1156]. Nat. Genet 2009, 41:1088-1093.
20. Hye A., Lynham S., Thambisetty M., Causevic M., Campbell J., Byers H.L., Hooper C., Rijsdijk F., Tabrizi S.J., Banner S., Shaw C.E., Foy C., Poppe M., Archer N., Hamilton G., Powell J., Brown R.G., Sham P., Ward M., Lovestone S. Proteome-based plasma biomarkers for Alzheimer's disease. Brain 2006, 129:3042-3050.
21. Johnson L.V., Leitner W.P., Rivest A.J., Staples M.K., Radeke M.J., Anderson D.H. The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A 2002, 99:11830-11835.
22. Johnson L.V., Leitner W.P., Staples M.K., Anderson D.H. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp. Eye Res 2001, 73:887-896.
23. Johnson L.V., Ozaki S., Staples M.K., Erickson P.A., Anderson D.H. A potential role for immune complex pathogenesis in drusen formation. Exp. Eye Res 2000, 70:441-449.
24. Klaver C.C., Ott A., Hofman A., Assink J.J., Breteler M.M., De Jong P.T. Is age-related maculopathy associated with Alzheimer's Disease?. The Rotterdam Study. Am. J. Epidemiol 1999, 150:963-968.
25. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
26. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De D.P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossu P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanche H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alperovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet 2009, 41:1094-1099. European Alzheimer's Disease Initiative Investigators.
27. Le Fur I., Laumet G., Richard F., Fievet N., Berr C., Rouaud O., Delcourt C., Amouyel P., Lambert J.C. Association study of the CFH Y402H polymorphism with Alzheimer's disease. Neurobiol. Aging 2010, 31:165-166.
28. Lovestone S., Francis P., Strandgaard K. Biomarkers for disease modification trials-the innovative medicines initiative and AddNeuroMed. J. Nutr. Health Aging 2007, 11:359-361. AddNeuroMed collaborative group.
29. Maller J., George S., Purcell S., Fagerness J., Altshuler D., Daly M.J., Seddon J.M. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet 2006, 38:1055-1059.
30. Maller J.B., Fagerness J.A., Reynolds R.C., Neale B.M., Daly M.J., Seddon J.M. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet 2007, 39:1200-1201.
31. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett 1989, 107:341-346.
32. McGeer P.L., McGeer E.G. The possible role of complement activation in Alzheimer disease. Trends Mol. Med 2002, 8:519-523.
33. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
34. Pham T.Q., Kifley A., Mitchell P., Wang J.J. Relation of age-related macular degeneration and cognitive impairment in an older population. Gerontology 2006, 52:353-358.
35. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 2007, 81:559-575.
36. Rogers J., Cooper N.R., Webster S., Schultz J., McGeer P.L., Styren S.D., Civin W.H., Brachova L., Bradt B., Ward P., et al. Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A 1992, 89:10016-10020. etA.l.
37. Schaumberg D.A., Hankinson S.E., Guo Q., Rimm E., Hunter D.J. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch. Ophthalmol 2007, 125:55-62.
38. Seddon J.M., Francis P.J., George S., Schultz D.W., Rosner B., Klein M.L. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007, 297:1793-1800.
39. Seddon J.M., Reynolds R., Maller J., Fagerness J.A., Daly M.J., Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest. Ophthalmol. Vis. Sci 2009, 50:2044-2053.
40. Strohmeyer R., Ramirez M., Cole G.J., Mueller K., Rogers J. Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain. J. Neuroimmunol 2002, 131:135-146.
41. Strohmeyer R., Shen Y., Rogers J. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Brain Res. Mol. Brain Res 2000, 81:7-18.
42. Turunen M., Vepsalainen S., Makinen P., Helisalmi S., Haapasalo A., Soininen H., Hiltunen M. No association between high temperature requirement 1 (HTRA1) gene polymorphisms and Alzheimer's disease. Neurobiol. Aging 2011, 32:547.e7-547.e9.
43. Veerhuis R., Nielsen H.M., Tenner A.J. Complement in the brain. Mol. Immunol 2011, 48:1592-1603.
44. Yates J.R., Sepp T., Matharu B.K., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Hayward C., Morgan J., Wright A.F., Armbrecht A.M., Dhillon B., Deary I.J., Redmond E., Bird A.C., Moore A.T. Complement C3 variant and the risk of age-related macular degeneration. N Engl J. Med 2007, 357:553-561. Genetic Factors in AMD Study Group.
45. Zetterberg M., Landgren S., Andersson M.E., Palmér M.S., Gustafson D.R., Skoog I., Minthon L., Thelle D.S., Wallin A., Bogdanovic N., Andreasen N., Blennow K., Zetterberg H. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet 2008, 147B:720-726.
46. Zhou J., Fonseca M.I., Pisalyaput K., Tenner A.J. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease. J. Neurochem 2008, 106:2080-2092.